华特达因(000915.SZ)：盐酸可乐定缓释片获得药品注册证书

Core Viewpoint - Huatai Dain (000915.SZ) announced that its subsidiary, Shandong Dain Marine Biological Pharmaceutical Co., Ltd. (referred to as Dain Pharmaceutical), has received a Drug Registration Certificate from the National Medical Products Administration for its product, Clonidine Hydrochloride Sustained-Release Tablets, which is intended for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents aged 6-17 years [1] Group 1 - The product is specifically used as a standalone or adjunctive treatment with central nervous system stimulants for ADHD [1]